The client was a research-based pharmaceutical company founded by leading global pharmaceutical executives. The company was the first of its kind in India to offer end-to-end development services to the global Pharma, Agro and Biotech industries and create long-term value for its shareholders. To expand its portfolio of offerings, the client wanted to evaluate opportunities in various services and sub-services of the drug discovery process which they can offer to its customers and at the same time accelerate their core expertise in drug discovery and development. The client requested UC Strategy to conduct opportunity assessment.
To assess opportunities in various services and sub-services of the drug discovery and development process in India, UC Strategy adopted the following approach:
- Triangulated primary and secondary research findings to obtain the market size, future growth and outsourcing trends for each service and sub-service segments in India
- Analysed the value proposition offered by various service segments in drug discovery and development process and scope for differentiation
- Developed summary snapshots for each service segment and identified salient macro trends and drivers likely to impact them in future
- Analysed the competitor landscape in different service and sub service segments
The client received a detailed opportunity assessment report on services and sub-services of each segment market in India, based on the future attractiveness.